Veracyte VCYT Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $541.74M+4.8% | $517.15M+4.4% | $495.14M+3.3% | $479.13M+3.4% | $463.39M+4.0% | ||
| —— | —— | —— | —— | —— | ||
| $384.18M+6.0% | $362.53M+6.8% | $339.31M+3.8% | $327.04M+3.8% | $315.19M+5.7% | ||
| 70.9%+0.8pp | 70.1%+1.6pp | 68.5%+0.3pp | 68.3%+0.2pp | 68%+1.1pp | ||
| $80.19M+13.2% | $70.81M+2.3% | $69.26M-2.2% | $70.85M-0.3% | $71.05M+2.5% | ||
| $102.87M+2.7% | $100.17M+1.1% | $99.05M+1.9% | $97.21M+1.1% | $96.11M+0.7% | ||
| $100.66M-9.1% | $110.78M-7.9% | $120.33M+1.3% | $118.79M+0.5% | $118.21M+6.9% | ||
| —— | —— | —— | —— | —— | ||
| $306.66M+0.6% | $304.76M-3.1% | $314.56M+0.4% | $313.21M+7.5% | $291.48M+3.4% | ||
| $77.52M+34.2% | $57.78M+133% | $24.76M+79.0% | $13.83M-41.7% | $23.7M+46.8% | ||
| 14.3%+3.1pp | 11.2%+6.2pp | 5%+2.1pp | 2.9%-2.2pp | 5.1%+1.5pp | ||
| $13.23M+26.9% | $10.42M+49.2% | $6.99M-56.0% | $15.87M+31.1% | $12.11M+17.2% | ||
| $90.75M+33.1% | $68.2M+120% | $31.01M+7.0% | $28.97M-17.4% | $35.08M+36.3% | ||
| —— | —— | —— | —— | —— | ||
| $88.01M+32.6% | $66.35M+119% | $30.32M+15.1% | $26.34M-20.3% | $33.05M+36.9% | ||
| 16.2%+3.4pp | 12.8%+6.7pp | 6.1%+0.6pp | 5.5%-1.6pp | 7.1%+1.7pp | ||
| $1.08+31.7% | $0.82+116% | $0.38+15.2% | $0.33-19.5% | $0.41+36.7% | ||
| $99M+25.0% | $79.19M+68.0% | $47.13M+28.0% | $36.81M-21.6% | $46.93M+18.5% | ||
| 18.3%+3.0pp | 15.3%+5.8pp | 9.5%+1.8pp | 7.7%-2.4pp | 10.1%+1.2pp | ||
| $77.52M+34.2% | $57.78M+133% | $24.76M+79.0% | $13.83M-41.7% | $23.7M+46.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Veracyte's profit margins?
- Gross margin is 70.9% and operating margin is 14.3%, with a 16.2% net margin.
- Where does Veracyte's income statement data come from?
- Every line is extracted from Veracyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.